Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 960
Last updated 2019-12-12
Summary
A case-control study to investigate whether job exposures are an under-recognized cause of idiopathic pulmonary fibrosis (IPF) using an interview to collect information about previous jobs and a blood test to investigate genetic susceptibility.
Conditions
Interventions
- OTHER
-
Computer-assisted telephone interview
Occupational history
- GENETIC
-
Genetic analysis
To include analysis of known susceptibility markers
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
University Hospital Southampton NHS Foundation Trust
collaborator OTHER -
Imperial College Healthcare NHS Trust
collaborator OTHER -
Heart of England NHS Foundation Trust
collaborator UNKNOWN -
Liverpool University Hospitals NHS Foundation Trust
collaborator OTHER_GOV -
Papworth Hospital NHS Foundation Trust
collaborator OTHER_GOV -
Nottingham University Hospitals NHS Trust
collaborator OTHER -
University Hospital of South Manchester
collaborator UNKNOWN -
Guy's and St Thomas' NHS Foundation Trust
collaborator OTHER -
North Bristol NHS Trust
collaborator OTHER -
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Newcastle-upon-Tyne Hospitals NHS Trust
collaborator OTHER -
Royal Devon and Exeter NHS Foundation Trust
collaborator OTHER -
Somerset NHS Foundation Trust
collaborator OTHER -
Royal Infirmary of Edinburgh
collaborator OTHER -
Morriston Hospital
collaborator UNKNOWN -
Aberdeen Royal Infirmary
collaborator OTHER -
Worcestershire Acute Hospitals NHS Trust
collaborator OTHER -
University Hospital Birmingham NHS Foundation Trust
collaborator OTHER -
Portsmouth Hospitals NHS Trust
collaborator OTHER_GOV -
Norfolk and Norwich University Hospitals NHS Foundation Trust
collaborator OTHER -
Glasgow Royal Infirmary
collaborator OTHER -
Imperial College London
lead OTHER
Principal Investigators
-
Carl Reynolds · Imperial College London
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-01
- Primary Completion
- 2019-10-05
- Completion
- 2019-10-05
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis
NCT04619199 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059 ·Status: COMPLETED ·Phase: NA
-
It's Not JUST Idiopathic Pulmonary Fibrosis Study
NCT03670576 ·Status: UNKNOWN
-
Clinical Genetics and Screening for Idiopathic Pulmonary Fibrosis
NCT06521125 ·Status: NOT_YET_RECRUITING
-
Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test
NCT03268915 ·Status: COMPLETED ·Phase: NA
-
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
NCT02315586 ·Status: COMPLETED
-
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF
NCT01874223 ·Status: COMPLETED
-
Quality of Life in IPF - Patient and Physician Perceptions
NCT04148157 ·Status: COMPLETED
-
Reliability and Validity of iOS in IPF
NCT04572971 ·Status: COMPLETED
-
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
NCT01110694 ·Status: COMPLETED
-
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis
NCT03104322 ·Status: COMPLETED ·Phase: NA
-
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
NCT03958071 ·Status: COMPLETED
-
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
NCT05503030 ·Status: ACTIVE_NOT_RECRUITING
-
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
NCT01154998 ·Status: UNKNOWN
-
Determination of Functional Exercise Capacity, Respiratory Muscle Endurance in Idiopathic Pulmonary Fibrosis
NCT06668051 ·Status: NOT_YET_RECRUITING
-
Characteristics and Health Related Quality of Life in Idiopathic Pulmonary Fibrosis
NCT03171870 ·Status: UNKNOWN ·Phase: NA
-
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258570 ·Status: RECRUITING
-
Families-At-risk for Interstitial Lung Disease Study
NCT03641742 ·Status: COMPLETED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00373841 ·Status: RECRUITING
-
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
NCT02632123 ·Status: COMPLETED